Macquarie Group
CLVS

Macquarie Group’s Clovis Oncology, Inc. CLVS Stock Holding History

Macquarie Group’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-250,200
Closed -$13K – 1818
2022
Q4 		$13K Hold
250,200
– – ﹤0.01% 1712
2022
Q3 		$298K Hold
250,200
– – ﹤0.01% 1579
2022
Q2 		$450K Sell
250,200
-17,862
-7% -$26.4K ﹤0.01% 1601
2022
Q1 		$541K Hold
268,062
– – ﹤0.01% 1637
2021
Q4 		$726K Hold
268,062
– – ﹤0.01% 1610
2021
Q3 		$1.2M Buy
268,062
+17,009
+7% +$81.9K ﹤0.01% 1544
2021
Q2 		$1.46M Hold
251,053
– – ﹤0.01% 1513
2021
Q1 		$1.76M Sell
251,053
-405
-0.2% -$2.71K ﹤0.01% 1244
2020
Q4 		$1.21M Hold
251,458
– – ﹤0.01% 1261
2020
Q3 		$1.47M Hold
251,458
– – ﹤0.01% 1135
2020
Q2 		$1.7M Buy
251,458
+151,258
+151% +$1.15M ﹤0.01% 1058
2020
Q1 		$637K Hold
100,200
– – ﹤0.01% 1208
2019
Q4 		$1.04M Hold
100,200
– – ﹤0.01% 1228
2019
Q3 		$394K Hold
100,200
– – ﹤0.01% 1418
2019
Q2 		$1.49M Hold
100,200
– – ﹤0.01% 1104
2019
Q1 		$2.49M Hold
100,200
– – ﹤0.01% 946
2018
Q4 		$1.8M Sell
100,200
-778,330
-89% -$15.9M ﹤0.01% 989
2018
Q3 		$25.8M Buy
878,530
+187,071
+27% +$7.24M 0.04% 416
2018
Q2 		$31.4M Buy
691,459
+75,589
+12% +$3.68M 0.05% 374
2018
Q1 		$32.5M Buy
615,870
+95,699
+18% +$5.58M 0.06% 346
2017
Q4 		$35.4M Sell
520,171
-6,709
-1% -$469K 0.06% 317
2017
Q3 		$43.4M Buy
526,880
+189,211
+56% +$15M 0.08% 239
2017
Q2 		$31.6M Buy
+337,669
New +$20.7M 0.06% 321

Other funds holding CLVS

RMC
Resources Management Corp West Hartford, Connecticut $794M AUM 25.46% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return

Macquarie Group's CLVS Position: Q1 2023 in Review

Macquarie Group sold out of Clovis Oncology, Inc. (CLVS) in Q1 2023, closing a stake of 250,200 shares — an estimated $13K sold.

Macquarie Group first reported a position in CLVS in Q2 2017 and held it in 23 quarters. The position peaked at $43.4M in Q3 2017. 2 funds tracked by Wall St. Rank hold CLVS as of Q1 2023.

  • Macquarie Group reported no remaining Clovis Oncology, Inc. position as of Q1 2023 after selling out during the quarter.
  • Macquarie Group sold 250,200 Clovis Oncology, Inc. shares in Q1 2023, an estimated $13K.
  • Macquarie Group first reported a position in Clovis Oncology, Inc. in Q2 2017 and held it in 23 quarters.
  • Macquarie Group's Clovis Oncology, Inc. position peaked at $43.4M in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2023.

Based on Macquarie Group's 13F filing for Q1 2023, filed 15 May 2023.